CNTA - Centessa Pharmaceuticals plc Profit before interest, taxes and amortization

Graphic logo of Centessa (CNTA)

Centessa Pharmaceuticals (CNTA) is facing a liquidity shortage and a gradual depletion of resources due to R&D expenditures. The trend in gross operating profit before depreciation reflects the current situation, where the value is maintained at 0.00. This is occurring against the backdrop of developing innovative therapies for sleep disorders and management's efforts to attract investment into autonomous research centers.

CNTA Centessa Corp: Profit before payment of interest, taxes and amortization in the range 11/23/2025 - 07/04/2026

Summary analytical data breakdowns for Centessa Pharmaceuticals PLC (CNTA)

Analysis of all company metrics:Centessa Pharmaceuticals
Manufactured product of Centessa Pharmaceuticals plc

This indicator measures net cash flow from operating activities before non-cash charges, allowing for the immediate identification of operational flow disruptions. By analyzing the recorded EBITDA level, an investor assesses the real liquidity of Centessa Pharmaceuticals (CNTA), which is critical given the absence of stable revenue and the company's reliance on external financing amid risky clinical trials.

Who Centessa Pharmaceuticals competes with

JAZZ: Operating profit before amortization|Cytokinetics Corp - Operating profit EBITDA|Profit before interest, taxes and amortization PTC Therapeutics Corp|SRRK (Scholar Rock, Inc.) - Operating profit before deduction of amortization|Dyne Corp - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Edgewise Therapeutics|RAPP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alumis Pharma (ALMS)|ZVRA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Contineum Pharma CTNM|Larimar Corp - Profit before payment of interest, taxes and amortization|CAPR - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Entrada Therapeutics|PTHS: Operating profit EBITDA|Operating profit before depreciation charges MediciNova, Inc. MNOV|Profit before payment of interest, taxes and amortization Serina Pharma|Profit before interest, taxes and amortization BioXcel BTAI|Profit before payment of interest, taxes and amortization ProMIS Neurosciences Inc. (PMN)|Operating profit EBITDA Apimeds Pharmaceuticals, Inc. (APUS)|Operating profit EBITDA AEON (AEON Biopharma, Inc.)|NLS Pharmaceutics AG - Profit before payment of interest, taxes and amortization|BNOX - Profit before payment of interest, taxes and amortization|HUGE (FSD Pharma Inc.) - Operating profit before amortization|RETA (Reata) - Operating profit before deduction of amortization